2018 Annual Meeting

Industry Supported Events


Industry-supported symposia, which have been made possible through marketing support, will be offered on Wednesday, Thursday and Friday evening, as well as Saturday morning during the meeting. Details on these programs are listed below, including how to register and who to contact for more information.

NOTE: Satellite symposia are supported by specific companies and are supported through a marketing grant. They are not part of the official program of the ASBrS and are free to all registered attendees.

WEDNESDAY EVENING SYMPOSIUM

Wednesday, May 2
7:30 pm–9:30 pm

Ambry Genetics
Ritz Carlton Ballroom IV

Screening or Scalpel: How genetic testing for hereditary breast cancer can guide patient care

Program Objective: To provide updated data regarding the clinical impact and future of multigene panel testing for patients at-risk for hereditary breast cancer

Description of Program: The identification of hereditary breast cancer through germline genetic testing can have significant implications on medical management, including changes to screening, surgery, and therapeutic planning. As the trend towards multigene panels continues, our understanding of hereditary breast cancer continues to evolve. This symposium will review updated data from >90,000 patients with a personal and/or family history of breast cancer who have undergone multigene panel testing, and will discuss how genetic testing can help you find more answers for your patients and their family members.

Click on the following link to register:  Ambry Genetics - Screening or Scalpel (Wednesday Night Symposium)

View invitation here

NOTE: This satellite symposium is supported by Ambry Genetics, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


THURSDAY EVENING SYMPOSIUM

Thursday, May 3
5:30 pm–7:30 pm

Genomic Health, Inc.
Mediterranean Ballroom
This event will be held immediately following the Coding and Reimbursement Symposium in the same room. 

Why Big Clinical Trials Still Matter And What To Expect From TAILORx
Panel:

  • Larry Norton, MD, Medical Oncologist, Deputy Physician-in-Chief for Breast Cancer Programs; Medical Director, Evelyn H. Lauder Breast Center; Norna S. Sarofim Chair in Clinical Oncology
  • Memorial Sloan Kettering Cancer Institute
  • Terry Mamounas, MD MPH, FACS, Medical Director, Orlando Health UF Health Cancer Center
  • Steve Shak, MD, Co-Founder & Chief Scientific Officer, Genomic Health

REGISTRATION INSTRUCTIONS: Please click HERE to register.

View invitation here

NOTE: This satellite symposium is supported by Genomic Health, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Friday Evening Symposia

Friday, May 4
Satellite Symposia
7:30 pm–9:30 pm

Programs:

Genentech, Inc.
Palazzo Ballroom A, JW Marriott

Presurgical Considerations for Patients with Early Breast Cancer

Program Overview:

  • Exploration of current ASCO/CAP testing recommendations and the association between tumor biology and treatment decisions prior to surgery
  • Review of current surgical guidelines and considerations for patients who have received pre-operative systemic therapy
  • Interactive case-study-based discussions on the role of the multidisciplinary team

To register, please log onto www.GeneRSVP.com and enter the program code: PRF83576.

Program details will be available shortly.  For more information, contact Kimberly Crespo at Kimberly.Crespo@IntraMedGroup.com.

View invitation here

NOTE: This satellite symposium is supported by Genentech, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Friday Evening Symposia


Invuity, Inc.
Palazzo Ballroom F, JW Marriott

Next Generation Hidden Scar® Breast Cancer Surgery: Novel Technologies and Techniques that Prioritize Survivorship

Program Objective: Discussion of new technologies and surgical techniques that are advancing and evolving Hidden Scar Breast Cancer Surgery

Description of Program: This symposium will discuss the advanced techniques, considerations, and enabling technologies in Hidden Scar Breast Cancer Surgery that prioritize both the oncologic and psychosocial outcomes essential for breast cancer survivorship. Faculty will discuss how advanced photonics, enhanced energy and fluorescence imaging technologies impact surgical experience and clinical outcomes in the evolving landscape in Hidden Scar breast cancer surgical treatment by exploring how oncoplastic techniques and philosophies are advancing breast conservation surgery, and how breast and plastic surgeons are working together to push boundaries in nipple sparing mastectomy and pre-pectoral breast reconstruction.

Click on the following link to register: https://invuity.com/2018hiddenscarsymposium/

View invitation here

Please contact Michelle Bohner at mbohner@invuity.com for more information.

NOTE: This satellite symposium is supported by Invuity, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Friday Evening Symposia


Saturday Breakfast Symposia

Saturday, May 5
6:15 am–7:45 am

Programs:

top of page


23andMe
Ritz Carlton Ballroom I-II

Underutilized to Ubiquitous: Genetic Testing for Breast Cancer

Program Objective: Discussion of new technologies and surgical techniques that are advancing and evolving Hidden Scar Breast Cancer Surgery

Description of Program: Genetic testing for breast cancer risk is finally becoming commonplace and routine in the clinic. But in addition to the tests ordered, physicians are now given genetic information from new sources, such as direct-to-consumer (DTC) testing, whole genome sequencing of people, whole exome sequencing of tumors, and others. Join Dr. Kevin Hughes, Co-Director, MGH Avon Comprehensive Breast Evaluation Center, Associate Professor, Surgery, Harvard Medical School, and Medical Director, Bermuda Cancer Genetics and Risk Assessment Clinic as he discusses how to manage the results of traditional genetic testing as well as the results of genetic tests physicians did not order.

Learning Objectives:

  • Recognize known genes implicated in breast cancer including common mutations and their ethnic distribution.
  • Discuss with patients the significance of reports related to DTC and other types of genetic testing for breast cancer susceptibility including probabilistic information, limitations of test results, implications for other family members, options for cancer surveillance and prevention.

Click on the following link to register: Symposium with Dr. Kevin Hughes

View Invitation Here

For more information, contact Rhea Daugherty at rhead@23andme.com

NOTE: This satellite symposium is supported by 23andMe through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Saturday Breakfast Symposia


Albert Einstein College of Medicine
Ritz Carlton Ballroom III

An Overview of an Anesthesiologist and Surgeon’s Effective Approach to Opioid Minimalization

View invitation here

Program Objective:

  • Discuss the benefits of opioid-sparing treatment regimens in the care of patients experiencing postsurgical pain
  • Review the effects of liposomal bupivacaine in managing postoperative pain following breast surgical procedures
  • Analyze  enhanced recovery after surgery (ERAS) care pathways that are aimed at improving the patient experience with recovery while reducing health care costs and complications
  • Review the multimodal options utilized pre-op, inter-op and post-op in breast reconstruction surgery
  • Identify the surgical anatomy targeting PECS I, II, III, serratus, classic tap, subcostal and rectus sheath blocks

Brief Summary/Description of Program:
An Overview of an Anesthesiologist and Surgeon’s Effective Approach to Opioid Minimalization is a live, one hour educational symposium. The symposium will include a faculty presentation, 3D cadaver demonstration, and questions and answers. It will provide the learners with the opportunity to interact with faculty in real time.

How to Register: Please click on the following link to register: www.eeds.com/live/710082.  For further information, call or email at 718-920-6674, cme@montefiore.org

Note: This satellite symposium is supported by Pacira Pharmaceuticals through an educational grant provided to Albert Einstein College of Medicine. CME credits for this program will be provided by Albert Einstein College of Medicine. It is not part of the official program of the ASBrS*. This activity is free to all registered attendees. (*An independent grant from Albert Einstein College of Medicine was provided to the ASBrS in order to offer this satellite symposium during the 19th Annual Meeting.)

back to Saturday Breakfast Symposia


Cianna Medical
Palazzo Ballroom F, JW Marriott

Moving Beyond Wires: Oncoplastic Techniques with SCOUT®

Join us for a hot breakfast buffet and learn more about SAVI SCOUT®, the only non-radioactive, non-magnetic, wire-free breast localization system for lumpectomy or biopsy with no significant MRI artifact.

View invitation here

How to Register:
Please click on the following link to register www.regonline.com/SCOUTatASBS2018 or please scan the QR code below

Cianna Medical QR Code

For more information, contact Lauren McGraw at lmcgraw@ciannamedical.com

NOTE: This satellite symposium is supported by Cianna Medical, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Saturday Breakfast Symposia


Focal Therapeutics, Inc.
Ritz Carlton IV

Improving Outcomes with Oncoplastic Surgery: Techniques in "Reconstructive Lumpectomy"

Summary of program:
Topics will include principles and practice of oncoplastic breast conserving surgery with specific attention focused on "reconstructive lumpectomy." Integration of the BioZorb implant will be covered including tips on patient selection, surgical techniques, and other "pearls" on how to optimize patient outcomes. The latest findings from the BioZorb Registry will also be presented.

Speakers: Linda Han, MD, FACS, Barry Rosen, MD, FACS, Cary Kaufman, MD, FACS

Seating is limited. Please RSVP by April 27, 2018 to kmurray@focalrx.com.

View invitation here

NOTE: This satellite symposium is supported by Focal Therapeutics through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Saturday Breakfast Symposia


ImpediMed, Inc.
Palazzo Ballroom A, JW Marriott

SOZO® - L-Dex®, Bilateral, Heart Failure, and we’re just getting started...

Are hydration, bone density and tissue analysis important to monitor in your patients? Come learn how ImpediMed is expanding and simplifying survivorship programs with our new SOZO® technology.

View Invitation Here

To register for the symposium, click here or cut and paste this link into your browser: https://www.regonline.com/builder/site/?eventid=2248625 For more information, contact Nick George at 760-585-2081 or ngeorge@impedimed.com.

NOTE: This satellite symposium is supported by ImpediMed, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


back to Saturday Breakfast Symposia

top of page